Loading... Please wait... Loading... Please wait...
ESTIMATED
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/29/2024 | Q1 2024 | -$0.59 | $0 | 03/15/2024 | Q4 2023 | -$3.10 | $5.39 M | 09/29/2023 | Q3 2023 | -$3.63 | $0 | 06/30/2023 | Q2 2023 | -$19.53 | $0 | 03/31/2023 | Q1 2023 | -$5.78 | $0 | 12/30/2022 | Q4 2022 | -$3.53 | $0 | 09/29/2022 | Q3 2022 | -$0.61 | $0 | 06/30/2022 | Q2 2022 | -$0.71 | $0 | 03/31/2022 | Q1 2022 | -$81.25 | $0 |
|---|
A. GRI Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for GRI Bio, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for GRI Bio, Inc.'s latest earnings report can be read online.
A. GRI Bio, Inc. (NASDAQ:GRI) has a recorded net income of $0. GRI Bio, Inc. has generated $-28.25 earnings per share over the last four quarters.
A. GRI Bio, Inc. (NASDAQ:GRI) has a price-to-earnings ratio of -0.39 and price/earnings-to-growth ratio is 0.
